Ramon Mendoza Johnson & Johnson

Ramon is the Scientific Director within the Cell and Gene Therapy Analytical Development group at Johnson and Johnson Innovative Medicine where he supporting the cell & gene therapy portfolio, leveraging his ATMP expertise. Prior to joining Janssen, Ramon worked for Bristol Myers Squibb (Celgene), Orchard Therapeutics, Rocket Pharma, Bayer Pharma and Analytical Lab Group now part of Element Materials Technology. During this time, Ramon had the responsibilities of leading analytical and commercial GMP quality teams, developing process and analytical control strategies for AAV, LV, RNP’s and CAR-T drug products. He has experience supporting Cell & Gene Therapy programs from early /late-stage development, well into the commercial lifecycle. He has authored many submissions and participated in agency inspection and meetings, leading to successful commercial approvals of new CAR-T drug products. Ramon has a PhD in Cell & Molecular Biology from the University of Washington, MS and BS in Biochemistry from San Francisco State University. He also held postdoctoral positions at the Fred Hutchinson Cancer Research Center in Seattle WA.